Create new account

Register now and get additional benefits:
  • Personal prices
  • Delivery tracking
  • Pre-filled and quick checkout
  • Order history and fast re-ordering
  • Exact product stock status
Cart

Your cart is empty, just add some products

This is a fantastic opportunity to fill the cart with something really special!

Estimated shipping

€0.00

Total: €0.00

image/svg+xml +372 5656 0050, +370 (620) 70159
ET
image/svg+xml Log in / Register
Log in or register
Log in Create account
Register now and get additional benefits:
  • Personal prices
  • Delivery tracking
  • Pre-filled and quick checkout
  • Order history and fast re-ordering
  • Exact product stock status
Cisbio0

Discover the newest additions to the HTRF® and Alpha portfolio

Cisbio launched several new target assays this week to further your research and drug discovery efforts. Learn more about the latest products and content.

Highlights:

  • Introduction of TYK2 kits in HTRF® format to complement the HTRF JAK1, JAK2, JAK3 kits
  • New AlphaLISA® C1q binding kit to support biologics development and characterization, in addition to our existing HTRF C1q assay
  • Additions to our E3 ligase portfolio to include HTRF VHL binding kits, AlphaLISA XIAP BIR2 binding kits, and XIAP BIR3 binding kits

See what's new

Neurodegenerative Disease Guide

IBD Drug Discovery Strategies

Explore this all-encompassing guide on the pathogenesis of neurodegenerative diseases, including the involvement of neuroinflammation and glial cells. Find key disease facts and background, in-depth molecular pathways, and more!

Lugege põletikulisele soolehaigusele (IBD) suunatud tipptasemel ravimiuuringute kohta ja erinevatest uuringuetappidest, kus on kasutatud homogeenseid HTRF® ja AlphaLISA® teste.

Identifying PROTAC Compounds

Enhance your PROTAC drug discovery efforts with this application note featuring experiments targeting Bruton Tyrosine Kinase (BTK). Discover the information needed to be successful in your research, including assay principles, materials and methods, and results.

A Unique Approach to GPCR Research

The most studied regulators of GPCRs are orthosteric ligands, leaving allosteric ligands a mystery. Researchers at the University of Montpellier recently conducted studies indicating that allosteric modulators of GCPRs hold promise for drug discovery. Learn more in this blog post.


Additional information: agnes@novabio.ee, +37253477200

Share

Contact

Nova Natura UAB

Chemijos G. 11, LT-51347,
Kaunas, Lithuania

nova@novabio.lt
Phone: +370 (620) 70159

Reg No 305063819

Nova Natura OÜ

Kanali tee 6, 10112,
Tallinn, Estonia

nova@novabio.ee
Phone: +372 5656 0050

Reg No 14758203

Let’s stay in touch

Join our newsletter!
Certification9001